Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China

Journal of Medical Virology

Volumn 85, Issue 11, 2013, Pages 1893-1899

  Yang, Yuan ^a   Jin, Li ^a   He, Ying Li ^a   Wang, Ke ^a   Ma, Xiao Hua ^b   Wang, Jing ^a   Yan, Zhi ^a   Feng, Yu Ling ^a   Li, Yong Qin ^c   Chen, Tian Yan ^a   Liu, Hong Li ^a   Zhao, Ying Ren ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Eighth Hospital   (China)

^c XI AN CENTRAL HOSPITAL   (China)

Author keywords

Cirrhosis; Family clustering; Genetic factors; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CHI SQUARE TEST; CHINA; CLINICAL FEATURE; CLUSTER ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; RELATIVE; SAMPLE SIZE; SPOUSE;

HEPATITIS B VIRUS;

CIRRHOSIS; FAMILY CLUSTERING; GENETIC FACTORS; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA;

ADOLESCENT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHINA; CLUSTER ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; YOUNG ADULT;

EID: 84883052145     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23649     Document Type: Article

References (36)

1. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ. 1989. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 321:708-712.
2. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, Gulcher JR, Bjornsson J, Kong A, Thorsteinsdottir U, Stefansson K. 2004. Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1:e65.
3. Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS, Szmuness W. 1983. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: Final report of a randomized double-blind, placebo-controlled trial. Hepatology 3:135-141.
4. Blumberg BS, Melartin L, Guint RA, Werner B. 1966. Family studies of a human serum isoantigen system (Australia antigen). Am J Hum Genet 18:594-608.
5. Bosch J, Brugera M, Rodes J. 1973. Familial spread of type-B hepatitis. Lancet 2:457.
6. Carrilho FJ, Ono-Nita SK, Cardoso RA, Cancado EL, Pinho JR, Alves VA, Da Silva LC. 2005. A prospective study of hepatitis B virus markers in patients with chronic HBV infection from Brazilian families of Western and Asian origin. Brazilian J Med Biol Res 38:1399-1408.
7. Chan AO, Yuen MF, Lam CM, Fong CY, Wong BC, Lai CL. 2004. Prevalence and characteristics of familial hepatocellular carcinoma caused by chronic hepatitis B infection in Hong Kong. Aliment Pharmacol Ther 19:401-406.
8. Chen YC, Chu CM, Liaw YF. 2010. Age-specific prognoses following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology 51:435-444.
9. Chu CM, Liaw YF. 2007. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 133:1458-1465.
10. Cooke GS, Hill AV. 2001. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2:967-977.
11. Frodsham AJ, Zhang L, Dumpi U, Taib NA, Best S, Durham A, Hennig BJ, Hellier S, Knapp S, Wright M, Chiaramonte M, Bell JI, Graves M, Whittle HC, Thomas HC, Thursz MR, Hill AV. 2006. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci USA 103:9148-9153.
12. Fujie H, Moriya K, Shintani Y, Yotsuyanagi H, Iino S, Koike K. 2001. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Gastroenterology 120:1564-1565.
13. Gerlich WH. 2006. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36:S18-S22.
14. Kane M. 1995. Global programme for control of hepatitis B infection. Vaccine 13:S47-S49.
15. Kao JH, Chen PJ, Lai MY, Chen DS. 2000. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554-559.
16. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, Kwang TY, Hsu ST, Lin SY, Hsu LC. 1989. Hepatitis B virus markers in Chinese twins. Anticancer Res 9:737-741.
17. Lin JB, Lin DB, Chen SC, Chen PS, Chen WK. 2006. Seroepidemiology of hepatitis A, B, C, and E viruses infection among preschool children in Taiwan. J MedVirol 78:18-23.
18. Liu J, Li Y, Chen T, Yang Y, Wang K, He Y, Yang Q, Ye F, Jin Y, Qiu T, Lin S, Liu M, Zhao Y. 2008. The distribution of HBV genotypes and clinical significance in familial clustering in an infected population with unfavorable prognoses. Arch Virol 153:2157-2161.
19. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. 2009. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis. J Natl Cancer Inst 101:1066-1082.
20. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. 1995. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 274:1201-1208.
21. Motta-Castro AR, Martins RM, Yoshida CF, Teles SA, Paniago AM, Lima KM, Gomes SA. 2005. Hepatitis B virus infection in isolated Afro-Brazilian communities. J Med Virol 77:188-193.
22. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135:796-800.
23. Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Haussinger D. 1996. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334:1422-1427.
24. Obayashi A, Okochi K, Mayumi M. 1972. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology 62:618-625.
25. Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K. 2004. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 19:670-675.
26. Ohkubo K, Kato Y, Ichikawa T, Kajiya Y, Takeda Y, Higashi S, Hamasaki K, Nakao K, Nakata K, Eguchi K. 2002. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer 94:2663-2668.
27. Sampliner R, Loevinger BL, Tabor E, Gerety RJ. 1981. Intrafamilial cluster of hepatitis B virus infection: Study of a large family in the United States. Am J Epidemiol 113:50-54.
28. Szmuness W, Prince AM, Hirsch RL, Brotman B. 1973. Familial clustering of hepatitis B infection. N Engl J Med 289:1162-1166.
29. Tong MJ, Weiner JM, Ashcavai MW, Redeker AG, Comparini S, Vyas GN. 1979a. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis 140:506-512.
30. Tong MJ, Weiner JM, Ashcavai MW, Vyas GN. 1979b. Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer 44:2338-2344.
31. Toukan AU, Sharaiha ZK, Abu-el-Rub OA, Hmoud MK, Dahbour SS, Abu-Hassan H, Yacoub SM, Hadler SC, Margolis HS, Coleman PJ. 1990. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol 132:220-232.
32. Wang WJ, Xu HW, Men BY. 1996. A genetic epidemiologic study on HBsAg chronic carriers. Zhonghua Liu Xing Bing Xue Za Zhi 17:148-151.
33. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ. 2002. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168-174.
34. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF. 2011. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis 203:646-654.
35. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, Liaw YF. 1997. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145:1039-1047.
36. Yuen MF, Lai CL. 2003. Screening for hepatocellular carcinoma: Survival benefit and cost-effectiveness. Ann Oncol 14:1463-1467.